These Analysts Raise Their Forecasts On Palantir Technologies After Q4 Results

Palantir Technologies Inc (NYSE: PLTR) reported upbeat sales results for its fourth quarter on Monday.

Palantir Technologies Inc (NYSE:PLTR) reported upbeat sales results for its fourth quarter on Monday.

Palantir said fourth-quarter revenue increased 20% year-over-year to $608 million, which beat the consensus estimate of $602.41 million, according to Benzinga Pro. Palantir reported quarterly adjusted earnings of 8 cents per share, which was in line with analyst estimates.

Palantir expects first-quarter revenue to be between $612 million and $616 million versus estimates of $617.21 million. First-quarter adjusted income from operations is expected to be between $196 million and $200 million.

Full-year 2024 revenue is expected to be between $2.652 billion and $2.668 billion. Full-year adjusted income from operations is expected to be between $834 million and $850 million. The company also guided for GAAP net income in each quarter of 2024.

Palantir Technologies shares fell 1.8% to close at $16.72 on Monday.

These analysts made changes to their price targets on Palantir Technologies after the company reported quarterly results.

  • Jefferies raised the price target on Palantir Technologies from $13 to $22. Jefferies analyst Brent Thill upgraded the stock from Underperform to Hold.
  • Raymond James raised the price target on Palantir Technologies from $22 to $25. Raymond James analyst Brian Gesuale maintained the stock with an Outperform rating.
  • Citigroup boosted Palantir Technologies price target from $10 to $20. Citigroup analyst Tyler Radke upgraded the stock from Sell to Neutral.

 

Check This Out: Ford, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday

Total
0
Shares
Related Posts
Read More

NeuBase Therapeutics Received A Notice On April 4, 2024 From The Listing Qualifications Department Of The Nasdaq Stock Market Notifying The Company That It Was Not In Compliance With Nasdaq’s Continued Listing Requirements Under Nasdaq Listing Rule 52…

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing Qualifications Department of The Nasdaq Stock

NBSE

Read More

Analyst Ming-Chi Kuo Says “Dell’s Total Server Shipments Are Expected To Return To Significant Growth Of About 15% YOY In 2024 Thanks To Strong AI Server Demand, Well Above The Industry Average Of 3–5% YOY” – Medium

https://medium.com/@mingchikuo/dells-total-server-shipments-are-expected-to-return-to-significnat-growth-of-about-15-yoy-in-2024-d40c85c3a57f My latest supply chain check indicates that the higher-than-expected

DELL